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The poliovirus mutant 5NC-ll has a 4-base insertion at position 70 within the 5' untranslated region and is
deficient in RNA synthesis. Revertants from 5NC-ll were isolated, showing a partial recovery of wild-type
levels of RNA synthesis. The 5' noncoding region of those revertants contained the mutation intact;
mix-and-match experiments with the cDNA from these revertants revealed that a restricted region within the
3C gene was the site of the suppressing mutations in the revertants. The suppressors were point mutations,
confirmed by introducing them into the 3C gene by site-directed mutagenesis. Although complementation
studies indicated that the suppressors were cis active, we believe that protein changes rather than RNA
sequence alterations are responsible for the suppression because RNA changes that did not alter protein
sequence had no effect, whereas various protein alterations were suppressive. The results therefore imply that
protein 3C interacts with the 5' end of the RNA and may play a role in RNA replication.
Poliovirus, a member of the picornavirus family, contains
a single plus-strand RNA genome of approximately 7.5
kilobases. There are two noncoding regions, at the 5' and 3'
ends, flanking a translated region of 6,528 nucleotides (4, 13).
Poliovirus RNA is translated into a single polypeptide,
which is processed into its smaller, functional proteins
mainly by the viral protease 3CPr0 with a few cleavages by
2APro (2, 19).
The 5' noncoding (5'NC) region shows marked sequence
and secondary structure conservation among the three po-
liovirus serotypes, suggesting that the 5'-terminal region
mediates crucial functions in the viral life cycle (14). We (20)
and others (12) have been able to delineate at least two
functional regions, one somehow involved in the synthesis of
the viral RNA (the first 100 nucleotides) and the other
involved in RNA translation (region P).
In an attempt to identify viral proteins that might interact
with the 5'NC segment of the RNA, we isolated revertants
from a mutant (5NC-11) that has a 4-base insertion at
nucleotide 70 and is deficient in RNA synthesis (20). These
revertants result from second site suppressor mutations
within the 3CPrO gene. The existence of such suppressors
strongly suggests a direct interaction between 3CPrO and the
far end of the 5'NC. 3CP"' may therefore play an unexpected
role in RNA replication.
MATERIALS AND METHODS
DNA procedures. Restriction enzymes, T4 DNA polymer-
ase, T4 DNA ligase, DNA polymerase I (Klenow fragment),
and human placenta RNase inhibitor were purchased from
Boehringer Mannheim Biochemicals, Indianapolis, Ind.;
avian myeloblastosis virus reverse transcriptase was from
Life Science Research, Baltimore, Md. All enzymes and
compounds were used according to the instructions of the
manufacturers. pGEM plasmids were from Promega Biotec
Co., Madison, Wis.
Standard cloning techniques were used (8). Plasmid
pPN-3, containing a mutation at nucleotide position 70, has
been described previously (20).
* Corresponding author.
The cDNA synthesis and cloning have been described in
detail elsewhere (8). Briefly, viral RNA obtained from CsCl-
purified virions was incubated with avian myeloblastosis
virus reverse transcriptase and oligo(dT). The second-strand
synthesis was performed by incubation of the heteroduplex
(viral RNA first strand) with RNase H and T4 DNA poly-
merase; the double-stranded cDNA synthesized was di-
gested with BgIII and cloned into a vector (pGEM-3 based)
containing the BglII site at the polylinker sequence, between
BglII and NruI sites. We generated two plasmids: p3A5',
containing a partial P1 region and a complete P2 and P3 until
the BglII site at position 5601; and p3A3', carrying cDNA
from the BglII site (position 5601) in the 3C gene to the
poly(A) (3' end).
Cells and virus. HeLa cells were grown as previously
described (1). HeLa cells on 100-mm dishes were transfected
with 1 to 5 ,ug of in vitro-synthesized RNA by using the
DEAE-dextran procedure (7). Individual plaques isolated
from transfection were grown by standard procedures, and
these stocks were used to analyze phenotypes.
Measurement of RNA synthesis. Suspension cultures of
HeLa cells (about 107 cells per ml) were infected at a
multiplicity of infection of 10. After adsorption at room
temperature for 30 min, Dulbecco modified Eagle medium
supplemented with 7% fetal calf serum was added. At
various times after infection cells were placed on ice,
washed once with cold phosphate-buffered saline, and lysed
in 10 mM Tris hydrochloride (pH 7.5)-10 mM NaCl-0.1%
Nonidet P-40. Nuclei and debris were removed by centrifu-
gation. RNA was isolated by phenol-chloroform extraction
and ethanol precipitation. Portions were denatured in lOX
SSC (lx SSC is 0.15 M NaCl-15 mM sodium citrate)-17%
formaldehyde and bound to nitrocellulose by aspiration with
a dot blot apparatus. Filters were baked for 2 h at 80°C under
vacuum. Hybridization was performed as described previ-
ously (20) with an antisense [32P]RNA probe generated with
T7 polymerase (9).
Nucleotide sequencing of RNA. Total cytoplasmic RNA
from infected HeLa cells was prepared as described above
and was sequenced by the chain-termination technique (15)
by using reverse transcriptase and synthetic oligonucleotide
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~~~~C-G
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UUAAAACAGC-GGCCCACGUGGCGGCUAG-CGCCUGUUUUAUACU
5NC-1 1
(mutant)
R3A and R6A
(revertants)
FIG. 1. Sequence at the 5'NC end of poliovirus RNA: (A) wild
type (type I, Mahoney) and (B) mutant 5NC-11. The sequences
determined by chain termination technique are displayed with
proposed secondary structures. The 4-base insertion in 5NC-11 is
indicated in larger type.
primers complementary to bases 102 to 124 and 6024 to 6045
of the viral RNA.
Site-directed mutagenesis. M13-rP3 was constructed for
mutagenesis of the 3C gene. Briefly, DNA from plasmid pT7
(containing a complete sequence of poliovirus type 1 [Ma-
honey] cDNA, downstream of a T7 RNA polymerase pro-
moter) was digested with BamHI and EcoRI, and a resulting
2,900-base-pair fragment (encoding the complete P3 region)
was electrophoretically purified. It was then cloned into the
BamHI-EcoRI sites of the replicative form of M13 mpl9.
The recombinant M13 contained poliovirus plus-sense se-
quences. Mutagenesis was carried out as described previ-
ously with uracil-enriched templates and specific mutated
oligonucleotides primers complementary to poliovirus RNA
sequences (5). Bacteriophages containing desired mutations
were plaque purified. The poliovirus-specific fragment was
excised from M13 replicative form by digestion with BglII
and ClaI and electrophoretically purified. This fragment was
then used as a substitute for the corresponding wild-type
fragment in pT7 or pPN-3 (20).
RESULTS
Mutant 5NC-11 and its revertants. The mutant 5NC-11 (20)
was generated by duplication of 4 bases near nucleotide
position 70 at the far 5' end of the genome, where two very
well conserved RNA loops are predicted by computational
analysis (14) (Fig. 1). This insertion produced a virus that
yielded minute plaques (Fig. 2B) and that was temperature
sensitive (the titer at 32°C was 200-fold that at 39°C). The
mutant had a dramatic deficiency in RNA synthesis (20)
(Table 1).
Revertants of this mutant were spontaneously generated
as large-plaque variants after one or two passages in HeLa
cells at 37°C (Fig. 2B and C). Two of those revertants, R3A
and R6A, were picked and grown up as stocks (their plaques
are shown in Fig. 2D and E).
R3A was still somewhat deficient in progeny production
and showed optimal growth at 37°C. R6A was even more
deficient, although much better than the 5NC-11 mutant, and
also had a 37°C optimum (data not shown).
Viral RNA and protein synthesis. Because mutant 5NC-11
has a major defect in RNA synthesis, we analyzed the ability
of the revertants to produce positive-strand viral RNA by
dot blotting. 5NC-11 produced only 0.1% of the wild-type
amount of RNA (Table 1), whereas R3A made 62% and R6A
produced 8.0%, both measured at their optimum tempera-
ture of 37°C. Both revertants showed cold and heat sensitiv-
ity of RNA synthesis, suggesting that their ability to produce
progeny was limited by their ability to make RNA under all
conditions.
Pulse-labeling experiments were performed to study the
ability of these revertants to synthesize and process viral
proteins. Overall protein synthesis was lower than that in the
wild type, probably as a consequence of the lower amount of
RNA template, but there was no evidence of any change in
the proteolytic digestion pattern (data not shown).
Location of suppressors. Total cytoplasmic RNA from
HeLa cells infected with the revertants was prepared, and
the nucleotide sequence from 1 to 100 was determined. The
very 5'NC region from R3A and R6A turned out to be
identical to that carried by the original mutant (5NC-11) (Fig.
1). To map the element responsible for the revertant pheno-
type, genomic RNA from purified R3A viral particles was
used as a template to synthesize cDNA. The cDNA was
cloned into a pGEM-3-derived plasmid, generating two
different plasmids, p3A3' and p3AP2 (see Materials and
Methods).
A series of cDNA recombinants between the plasmid
containing the insertion at nucleotide 70 (pPN-3) and dif-
ferent R3A cDNA fragments was constructed (Fig. 3), and
the phenotypes of the resulting viruses were tested by plaque
assay. Plasmid pNB-2 contained a full-length poliovirus
cDNA, in which part of P1, all of P2, and a part of the P3
regions came from R3A cDNA (Fig. 3). When RNA derived
from pNB-2 was transfected into HeLa cells, the plaque size
of the resulting virus resembled that of the 5NC-11 mutant.
By contrast, replacement of the wild-type 3' end with cDNA
from the revertant generated a plasmid, pB3'end, whose
RNA transcript produced the plaque size of the R3A rever-
tant virus when transfected into HeLa cells. Other plasmids
mapped the suppressing locus to a fragment extending from
nucleotide positions 5601 to 6056 of the R3A genome (Fig.
3). When this 455-base-pair cDNA segment was sequenced,
a single substitution, C to T at nucleotide position 5898, was
found within the gene 3CprO (the viral protease). Sequencing
of R6A RNA revealed a different single base change also in
the 3CPrO gene, 6 nucleotides downstream from the R3A
substitution (Fig. 4).
To confirm that those changes really suppressed the
5NC-11 defect, we produced the same alterations directly in
the mutant genome. Synthetic oligonucleotide primers were
used to change C5898 to T (p11T) and A59 to G (p11G) (see
Materials and Methods) (Fig. 5). When RNA derived from
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FIG. 2. Phenotype of mutant 5NC-11 and its revertants. In the plaque assay shown, HeLa cells were inoculated with the wild type, mutant,
or revertants from master stocks, incubated at 37°C for approximately 40 h, and then stained. (A) Wild type; (B and C) mutant 5NC-11, first
and second passage, respectively (the larger plaques are spontaneous revertants); (D) revertant R3A; (E) revertant R6A.
pllT and pllG was used to transfect HeLa cells, the viruses
recovered had the plaque sizes of R3A and R6A, respec-
tively (Fig. 5). Thus, independent mutated cDNAs obtained
in this manner were able to reproduce exactly the pheno-
types observed in R3A and R6A revertants (as assessed by
plaque size), supporting the idea that C5898 to T and A5904 to
G are the alterations needed to suppress the defect present in
5NC-11.
When the 3C alterations in R3A and R6A were inserted
into a wild-type background, the Thr-to-Ile change in R3A
had a plaque size approximately that of R3A, whereas the
TABLE 1. Synthesis of positive-strand poliovirus RNA
% of wild-type RNA synthesis
Virus
32°C (7 h)a 37°C (4 h) 39°C (4 h)
5NC-11 NDb 1.1 ND
R3A 37 62.0 9.7
R6A 2.8 8.0 2.1
a Numbers within parentheses indicate hours postinfection.
b ND, Not determined.
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(mutant)
-AAA 3' R3R
(reuertant)
-AAA 3' 5NC-11
Il (mutant)
5)
-AAA 3' R30
(reuertant)
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FIG. 3. Maps of full-length poliovirus cDNAs used to generate recombinant virus. The poliovirus genetic map is shown at the top (thin
line, nontranslated regions; boxes, open reading frame with the location of the viral proteins). The triangles at the 5' untranslated region
indicate the 4-base insertion at position 70 (Fig. 1B). The cDNA inserts of different plasmids are shown below with the different restriction
enzymes used in the constructions. Stippled bars indicate cDNA obtained from R3A revertant RNA; clear bars represent cDNA from the wild
type, type I (Mahoney). The name of each plasmid is shown at the left, and the plaque assay phenotype obtained after transfection with RNA
synthesized from that plasmid is shown at the right.
5NC-1 1, R3A and R6A
AUtUGCGGAC GUAC CCUUGU
70
Bgl 11(5601) Hind 111 (6056)
3
5' _ |V2|V3 |Vp1 |A 2B 2C I 3A 3C; 3D _WAAA 3'
Vp4
5NC-1 1
R3A
R6A
Vpg
UGU ACU GGG AAA GUC AUC
C T G K V I
UGU AU GGG AAA GUC AUC
C I G K V I
UGU ACU GGG AGA GUC AUC
C T G R V I
FIG. 4. Nucleotide sequence for 5NC-11, R3A, and R6A at the 5' untranslated region and the 3CPrO gene. The restriction enzyme sites
flanking the 3C-3D fragment (see the text) are indicated. The nucleotide and amino acid changes are indicated by boldface characters and
arrows.
Plasmids
NheI
(2470)
pBP-l 5'
pBH-3 5 _.rE
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FIG. 5. Site-specific mutagenesis. The sequence at the 3CPFO
gene is shown. Changes that have been introduced are indicated in
larger type. The name of each plasmid is shown at the left, and the
phenotype of the virus generated after transfection with the RNA
made from that plasmid is shown at the right. For all plasmids the
first base of the sequence is 5894, and the amino acid coded for by
the first codon is no. 153 of the 3C protein.
conservative Lys-to-Arg change in R6A generated a virus
with a plaque size about equal to that of the wild type.
Furthermore, the R3A lesion generated a virus that pro-
duced a slightly higher titer than did R3A as seen in a
one-step growth curve. However, the same virus showed no
difference from R3A with respect to the amount of viral
RNA and protein synthesized, nor did it differ in terms of the
processing of the polyprotein into its final products.
Silent mutation still conserves the phenotype. The suppres-
sor of the 5NC-11 could either work through protein or
directly by RNA-RNA interaction. We attempted to use
complementation analysis, but the result yielded no infor-
mation because the function appeared to be cis active (data
not shown). Thus, to determine whether it was the 3CPrO
protein or the RNA itself of this region that had the suppres-
sor function, we generated silent mutations by changing
particular codons to different ones encoding the same amino
acid (Fig. 5). A clone with three silent changes in the region
of 3CPrO where the suppressor mutations occurred was wild
type, indicating that conservation of RNA structure in this
region is not crucial.
Furthermore, when codon ATT154 of the R3A 3CP'° gene
was substituted by ATA in the plasmid containing the 4-base
insertion at the position 70 (Fig. 5; pllTA), the change,
which did not modify the amino acid sequence, did not alter
the phenotype of the virus generated. Similarly, when codon
AGA156 of the R6A 3CPr° gene was replaced by CGC, a
mutation which conserves the R6A 3C protein sequence, we
recovered virus with the R6A phenotype.
Thus, although the data is fragmentary, they suggest that
it is protein 3C rather than the RNA that carries out the
suppressor function of the R3A and R6A revertants. Also,
the various poliovirus types show variety in the RNA
sequence in this region, indicating no tendency to maintain
any particular RNA structure (10, 16-18).
RHINOVIRUS 14
...AUC ACA UGU ACU GGG AAA UCA UCG GGA...
.1 T C T G K S S G...
...AUC ACC UGC ACU GGC AAG GUC AUC GGG...
.1 T C T G K V I G...
...CUC AUG UCC ACC GGC AAG GUA CUG GGU...
...L M S T G K V L G...
...CUG UGU GCU ACU GGU AAG AUC UUU GGU...
...L C A T G K I F G...
FIG. 6. Alignment of poliovirus types I and II, coxsackievirus
B3, and human rhinovirus 14 sequences at the 3CPFO gene.
DISCUSSION
Starting with a mutant in the far 5' untranslated segment of
poliovirus RNA, we isolated revertants that, surprisingly,
mapped to a protease gene, 3CPrO. Two observations suggest
that it is the protein 3C or one of its precursors, rather than
the RNA sequences encoding 3C, that has the ability to
suppress the 5NC-11 mutation. First, mutations affecting 3C
RNA sequence but not the protein did not modify the
phenotype of either the wild type or the revertants (Fig. 5).
Second, in this particular region of 3C, the amino acid
sequence (Thr-Gly-Lys) is highly conserved among different
strains of poliovirus and other picornaviruses, whereas the
RNA sequences differ significantly (Fig. 6). Interestingly,
intertypic recombinant viruses between poliovirus types I
and II (6) and between poliovirus and coxsackievirus (3)
have been constructed. These recombinants, carrying 5'NC
regions from one virus and 3C from another, generate
wild-type virus, showing no indication of a specific interac-
tion between the RNAs of the 5'NC region and the 3C
region.
Thus, substitutions at the 3C protein appear to compen-
sate for a mutation in the 5'NC region which could only
affect RNA structure. This observation suggests strongly
that a protein carrying 3C sequences must interact physically
with RNA structures within the 5'NC region and that this
interaction would be somehow affected by the mutation at
nucleotide 70. We imagine that the mutationally altered
interaction between 5'NC RNA structure and protein 3C is
returned toward normal by readapting 3C to the mutated
binding site. This readaptation of 3C can occur by means of
the secondary mutations in the revertants R3A and R6A.
To interpret the meaning of the proposed interaction
between protein 3C and the region around nucleotide 70 of
the viral RNA, we need to understand the physiologic
consequences of the lesion in mutant 5NC-11. This is a
highly defective virus, yielding few progeny even at low
temperature. It makes little viral RNA, and that might be its
primary defect. However, viral RNA synthesis requires
formation of correct viral proteins, implying that 5NC-11
could either be mutant in viral RNA synthesis directly or in
formation of the active components of the RNA replication
machinery. For instance, a defect in cleavage of the poly-
protein precursor of the functional polypeptides could give
an equivalent phenotype. Because 5NC-11 reverts easily and
the revertants then go through a normal life cycle, obscuring
the products of 5NC-11, we are uncertain exactly what is the
physiologic consequence of the insertion in the mutant.
If 5NC-11 does have a defect in protein cleavage, then the
data would indicate the 3CPrO requires an interaction with the
5' end of the RNA for it to be appropriately active. This
pT7-polio
pGTG XpA
pllT
pllTA
pl1G
pllGCG
Wild-type POLIOVIRUS, TYPE I(MAHONEY)
POLIOVIRUS, TYPE II
Wild-type (LANSING)
COXSACKIEVIRUS B3
UGU ACU GGG AAA GUC AUC
C T G K V I
UGU ACG GGIJ AAG GUC AUC
C T G K V I
UGU AlIU GGG AAA GUC AUC
C U G K V I
UGU AVUA GGG AAA GUC AUC
C U G K V I
UGU ACA GGG AG3A GUC AUC
C T G IR V I
UGU ACA GGG VGC GUC AUC
C T G IR V I
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would readily explain the data and would suggest that viral
RNA is a cofactor of protease action. The 3C protease
translated from an RNA lacking the poliovirus 5'NC se-
quence, however, carries out at least some cleavages (11),
making the hypothesis unlikely. More likely is that the 3C
region of polypeptide has a critical function in viral RNA
synthesis that is manifest through its binding to the stem-
loop region around nucleotide 70 of the 5'NC region. One
possible function for 3C in replication relates to the VPg
protein on the 5' end of viral RNA. This protein is mainly
found in the cell as a precursor (3AB) from which it
apparently cleaved at a Gln-Gly bond, the primary substrate
for 3CPrO cleavage. Thus, 3Cpr" may bind into the initiation
complex to coordinate VPg cleavage from 3AB, and the
structure around nucleotide 70 may provide the binding site.
We are presently attempting to derive alleles of 3CPro or
5'NC that would be more amenable to physiologic analysis
to test these possibilities.
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